Progesterone receptors are not confined to the uterus. They are present in the brain, in bone, in breast tissue and in the cardiovascular system, and the hormone is metabolized to compounds that act directly on receptors in the central nervous system. That is the starting point for this page, because it is the part of the picture that usually goes unmentioned.
The question most women arrive with is narrower: after a hysterectomy, do I still need progesterone? The short answer is no — and understanding exactly which question that answer belongs to is worth a few minutes.
Where the receptors are
Progesterone acts wherever there are receptors for it, and those are distributed well beyond the reproductive tract. Oral micronized progesterone is metabolized to allopregnanolone, which acts on GABA-A receptors — the same receptor family that sedatives act on. That mechanism is characterized in humans, it is not in dispute, and it is the reason micronized progesterone is conventionally taken at night rather than in the morning.
William Clearfield, D.O., presenting to the Age Management Medicine Group, makes the point directly: the conventional position that a woman who has had a hysterectomy no longer needs progesterone sits alongside the fact that progesterone receptors appear in the kidney, cardiovascular, respiratory, gastrointestinal, central nervous and bone remodeling systems. We would treat that as a clinician's argument for looking wider rather than as settled proof of a benefit — the reference list behind it is not publicly available and we have not been able to check it.
What endometrial protection is, and when it stops applying
In women taking systemic estrogen who still have a uterus, progesterone — or another progestogen — is prescribed to protect the endometrium. Unopposed estrogen stimulates the uterine lining, and over time that stimulation raises the risk of endometrial hyperplasia and endometrial cancer. Adding a progestogen prevents it.
Remove the uterus and you remove the tissue being protected. That indication no longer applies. Prescribing progesterone routinely for endometrial protection in a woman without a uterus would be treating a risk that no longer exists.
This part is settled, it is not controversial, and nothing on this page disputes it.
The inference that does not follow
"Progesterone is not required to protect the endometrium" is a statement about one tissue and one indication.
"Progesterone does nothing else for you" is a different statement, and it does not follow from the first. The endometrial indication was established to answer a specific safety question. It was never an inventory of everything the hormone does.
That distinction is the whole of the disagreement patients run into, and most of the time both sides are right about different things.
What is actually established beyond the uterus, and at what level
Being honest about the evidence level matters more here than in most places, because this is a topic where confident claims are made in both directions.
- The mechanism — progesterone to allopregnanolone to GABA-A modulation — is established human pharmacology.
- The sleep work is where the clinical evidence is strongest, and it is narrower than it is usually described: pooled trial data supports falling asleep faster, while total sleep time and sleep efficiency have not separated convincingly from placebo.
- The mood literature is genuinely mixed, and a subset of women respond with low mood rather than improved mood.
- The neuroprotection work is preclinical and has already failed to translate once in large human trials. It should not factor into anyone's decision today.
We have written all of that up separately, with the citations attached.
How we approach it
We do not prescribe progesterone after hysterectomy as a matter of routine. There is no basis for it, and a receptor map is not an indication.
Where it comes up is narrower. A patient without a uterus describes a sleep problem that has not responded to the usual approaches, and a trial of micronized progesterone is a reasonable thing to discuss on its own merits — as a treatment for that symptom, with a defined review point, not as a standing part of a hormone protocol.
That is an individual decision, and it should be made with the evidence stated as it is: a mechanism that is well characterized, clinical support that is real but narrower than the marketing suggests, individual response that varies, and no requirement of hormone therapy in your situation.
What to ask
- Am I being offered progesterone for endometrial protection, or for another reason?
- If for another reason, what is the evidence, and how strong is it?
- What are we measuring to decide whether it worked?
- When do we stop if it does not?
Frequently asked questions
Do I need progesterone if I've had a hysterectomy?
Not for endometrial protection. That is the established indication, and without a uterus it does not apply.
Then why do some providers prescribe it anyway?
Usually for sleep or mood rather than for the uterus. That is a different clinical decision and should be presented as one, with its own reasoning and its own review point.
If progesterone receptors are everywhere, shouldn't everyone take it?
No. A receptor is a place a hormone can act, not evidence that giving more of it produces a benefit. The two questions get conflated constantly, and the second one is answered by clinical evidence rather than by a receptor map.
Is there a difference between progesterone and progestins?
Yes. Micronized progesterone is structurally identical to the hormone the body produces. Synthetic progestins are different molecules with different effects, and research findings about one do not automatically transfer to the other.
Does taking progesterone after hysterectomy carry risk?
Any prescription carries considerations. Discuss them specifically with your clinician rather than assuming a hormone is risk-free because it is bioidentical.
